
Is Doxycycline Appropriate for Routine Treatment of Young Children With Erythema Migrans?
Author(s) -
Gary P. Wormser,
Franc Strle,
Eugene D. Shapiro
Publication year - 2019
Publication title -
the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000002453
Subject(s) - doxycycline , erythema migrans , dermatology , lyme disease , medicine , erythema , erythema chronicum migrans , borrelia burgdorferi , pediatrics , immunology , antibiotics , lyme borreliosis , microbiology and biotechnology , biology , antibody
The frequency of permanent staining of teeth of young children from doxycycline is thought to be lower than from older tetracyclines, but the precise risk is uncertain. Until more definitive data become available, doxycycline should not be used routinely to treat young children with erythema migrans, a manifestation of Lyme disease for which other antimicrobials are highly effective.